The association between serum cadmium and diabetes in the general population: A cross-sectional study from NHANES (1999–2020)

Abstract

BackgroundAssociations between serum cadmium and diabetes had been reported in previous studies, however there was still considerable controversy regarding associations. Studies in general population that investigated the effects of serum cadmium on diabetes were currently lacking. We designed this cross-sectional study among U.S. adults under high and low cadmium exposure to assess associations between serum cadmium and diabetes.MethodsThis cross-sectional study analyzed 52,593 adults who aged more than 20 years and participated in the National Health and Nutrition Examination Survey (NHANES), 1999–2020. The missing values and extreme values in the covariables were filled by multiple interpolation. Univariate logistics regression, multivariate logistics regression and smooth fitting curves were used to analyze the association between serum cadmium and diabetes. Simultaneously, sensitivity analysis was carried out by converting the serum cadmium from continuous variable to categorical variable. The stratification logistics regression model was used to analyze whether there were special groups in each subgroup to test the stability of the results.ResultsIn this cross-sectional study, serum cadmium levels were negatively correlated with the occurrence of diabetes in the low serum cadmium exposure group (OR = 0.811, 95% CI 0.698, 0.943; P = 0.007). There was no association between serum cadmium level and the occurrence of diabetes in the high serum cadmium exposure group (OR = 1.01, 95% CI 0.982, 1.037; P = 0.511). These results were consistent across all the subgroups (P for interaction >0.05).ConclusionSerum cadmium was negatively associated diabetes among the representative samples of the whole population in the United States under the normal level of serum cadmium exposure. However, there was no association between serum cadmium level and the occurrence of diabetes in the high serum cadmium exposure group. This study promoted an update of new preventative strategy targeting environment for the prevention and control of diabetes in the future.

WITHDRAWN: Association between dietary inflammatory index and Parkinson’s disease from NHANES (2003–2018): a cross-sectional study

“…In this study, nine cycles of NHANES data (2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018) were collected by the Centers for Disease Control and Prevention (CDC). NHANES is a multi-stage, strati ed, large, nationally representative study of the United States population that provides detailed information about the study design, interviews, demographics, etc [5,13,14] . Among the sample of 80,241 adults, who did not provide dietary information or other variables, were excluded (Fig.…”

Association between metal mixture exposure and abnormal glucose metabolism in multiple mixture exposure models: Evidence from NHANES 2015–2016

“…Notably, a meta-analysis found that Cd exposure was positively associated with the risk of both type 2 diabetes and prediabetes with moderate-certainty evidence ( Filippini et al, 2022 ). However, a cross-section study from NHANES suggested Cd exposure upper the normal level was not associated with diabetes in the general people from 1999 to 2020 ( Gong et al, 2022 ). The reason for the inconsistency with our results may be the neglect of synergistic toxic effects from other metals and the prediabetes not included in the analysis.…”

Association between serum heavy metal levels and diabetic retinopathy in NHANES 2011–2020

“…An observational study showed that higher Mn intake was directly associated with a lower risk of type 2 diabetes in a population of postmenopausal women 7 . Previous study found a negative association between typical levels of serum Cd and diabetes risk in a United States of America population aged 20 years or older 8 . Kornhauser et al reported that plasma Se was negatively associated with the severity of diabetic nephropathy in patients with type 2 diabetes 9 .…”